morning all,
I will reply to 18041970 on this thread because it is more relevant than in a charting thread.
Re. the news ann. - this is at bare minimum confirmation that the company thinks that it is worth running with for another year - it could also mean that they are excited about it --------- only time will tell.
"What MedAdvisor appears to do quite well, is simply medication management."
Actually - it does it more than quite well from what I see - it does it very well.
"Competition, especially in the "Consumer App" space is always something I am wary of with these...."
Competition in the app. space is a constant --------- but, apps. are no different to any other business - an app. is really only the front end ------------ 'everything' behind it has to work and work well and integrate well for an app. or a business to perform well ----------- which, makes the 'app. competition' thing - fairly minor in reality.
That the app. needs to be good - yes, is crucial - but, a perfect app. is not worth a cent - if pharmacies don't get behind it or people don't use it.
It is pretty clear that this app. has that happening - and, yes, there is 'some' resistance in some quarters - but, there always are resistant quarters in technological change. I worked for a while in a Govt' department where the 'boss' resisted going to email from snail mail ------------- can you believe such a dinosaur act? -- Of course - eventually - and rapidly - the dinosaur was swept away in the rush of the tide of progress.
So - if this thing continues - most will change to it --------- bar perhaps the very old - who aren't into technology.
The big possible resistors in this are the doctors etc. -- they are dinosaurs - still, many records on paper - still some are handwriting - and, still many 2 fingered typists among them.
But, - the tide will sweep them away very very rapidly as well - it won't be MDR that will do it by itself --- AI is coming like a train - robot surgery is here - and digital records are here - and, none will survive if they don't convert.
The only questions for MDR are -- is the timing right? and can the company get the revenue they want from what areas they want - and, what other revenue areas will open up?
One thing in this world that works is money. It may well be the root of all evil - but, it is in fact the biggest driver of all (broadly) - if there is enough money to be made or enough money to be saved - AND it can be demonstrated - with little outlay or risk - then people will go for it ------------ even the medical profession.
Medication is a really really big deal in life ----------------- inappropriate medication is one of the biggest killers and injurers in our society - it is also one of the biggest costs - it is also one of the biggest areas of waste.
ANY company that can come in and hit this space with a money saving and/or making idea that runs - WILL do well - very well - it's that simple.
"Big risks, still not going to be profitable for a while yet (although the actual, existing revenue is a nice change from many others) so its far from a sure thing. I'm in for a punt, grabbed a few more today.. if this does a RAP, I don't want to miss it but not under any illusions that its a sure-thing."
Agree with the above ----------- there are just not enough runs on the board yet - and, in my case, not enough known about the team and team dynamic yet to make a high conviction buy - but, at the stage it is at -- IMO - it's worth a reasonable punt - and, if it comes off - it will pay handsomely. If it doesn't - then, I think it will be a low risk - or at least low loss punt/investment.
We shall see.
have a great day all.
- Forums
- ASX - By Stock
- Ann: GlaxoSmithKline Extends Service Agreement with MedAdvisor-MDR.AX
morning all, I will reply to 18041970 on this thread because it...
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MDR (ASX) to my watchlist
(20min delay)
|
|||||
Last
30.0¢ |
Change
0.010(3.45%) |
Mkt cap ! $215.0M |
Open | High | Low | Value | Volume |
29.0¢ | 30.0¢ | 27.5¢ | $254.8K | 889.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 39326 | 30.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
30.5¢ | 2917 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 15939 | 0.335 |
3 | 26030 | 0.330 |
1 | 100000 | 0.325 |
4 | 89161 | 0.320 |
2 | 29526 | 0.315 |
Price($) | Vol. | No. |
---|---|---|
0.360 | 24455 | 1 |
0.380 | 50000 | 1 |
0.385 | 100000 | 1 |
0.390 | 54500 | 1 |
0.395 | 10000 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
MDR (ASX) Chart |